Citigroup Portfolio holdings
Citigroup is a multinational investment bank and financial services company, formed in 1998 when Citicorp, the holding company for Citibank, merged with Travelers. Citibank dates to 1812, when it was chartered as City Bank of New York to serve a group of local merchants. In 2009 it merged its Smith Barney brokerage and wealth unit with Morgan Stanley's into a joint venture, and in 2013 it sold its remaining stake to Morgan Stanley. Its businesses cover investment, corporate and commercial banking, sales and trading in the markets, cash management and trade finance for companies, wealth management, and credit cards in the United States.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$2.36B |
| 2 |
Tesla
TSLA
|
+$1.09B |
| 3 |
Amazon
AMZN
|
+$1B |
| 4 |
Microsoft
MSFT
|
+$963M |
| 5 |
Apple
AAPL
|
+$864M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Russell 2000 ETF
IWM
|
+$1.22B |
| 2 |
Bank of America
BAC
|
+$1.2B |
| 3 |
State Street Energy Select Sector SPDR ETF
XLE
|
+$381M |
| 4 |
First Trust Dow Jones Internet Index Fund ETF
FDN
|
+$294M |
| 5 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$248M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 39.44% |
| 2 | Technology | 25.75% |
| 3 | Financials | 6.27% |
| 4 | Consumer Discretionary | 5.79% |
| 5 | Industrials | 5.08% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
2251
AdvisorShares Pure US Cannabis ETF
MSOS
$832M
| $4.25M | ﹤0.01% |
837,309
-51,453
| -6% | -$241K |
2025 Q3
3 quarters
|
|
2252
The Bancorp
TBBK
$1.88B
| $4.25M | ﹤0.01% |
67,816
-11,558
| -15% | -$662K |
2013 Q2
52 quarters
|
|
2253
CALL
First Majestic Silver
AG
$6.95B
| $4.24M | ﹤0.01% |
250,000
| – | – |
2026 Q1
1 quarter
|
|
2254
Mizuho Financial
MFG
$115B
| $4.24M | ﹤0.01% |
442,623
+12,445
| +3% | +$112K |
2013 Q2
52 quarters
|
|
2255
Tarsus Pharmaceuticals
TARS
$3.43B
| $4.24M | ﹤0.01% |
67,298
+12,963
| +24% | +$828K |
2020 Q4
22 quarters
|
|
2256
Arbutus Biopharma
ABUS
$792M
| $4.22M | ﹤0.01% |
879,237
-19,184
| -2% | -$84.2K |
2013 Q4
50 quarters
|
|
2257
OneMain Financial
OMF
$6.56B
| $4.22M | ﹤0.01% |
69,214
-36,141
| -34% | -$2.04M |
2013 Q4
50 quarters
|
|
2258
Newell Brands
NWL
$2.54B
| $4.22M | ﹤0.01% |
687,147
+157,117
| +30% | +$664K |
2013 Q2
52 quarters
|
|
2259
SSR Mining
SSRM
$5.33B
| $4.2M | ﹤0.01% |
148,538
+129,159
| +666% | +$3.93M |
2017 Q3
35 quarters
|
|
2260
MGIC Investment
MTG
$5.87B
| $4.19M | ﹤0.01% |
148,483
+10,279
| +7% | +$274K |
2013 Q2
52 quarters
|
|
2261
Green Plains
GPRE
$986M
| $4.19M | ﹤0.01% |
272,186
-810
| -0.3% | -$12.9K |
2013 Q2
52 quarters
|
|
2262
Bank of Hawaii
BOH
$2.79B
| $4.18M | ﹤0.01% |
51,352
+5,586
| +12% | +$437K |
2013 Q2
52 quarters
|
|
2263
Weatherford International
WFRD
$6.45B
| $4.18M | ﹤0.01% |
51,344
-37,961
| -43% | -$3.85M |
2021 Q4
18 quarters
|
|
2264
Pembina Pipeline
PBA
$28.7B
| $4.18M | ﹤0.01% |
90,387
-1,688
| -2% | -$78.1K |
2013 Q2
52 quarters
|
|
2265
Core Natural Resources Inc
CNR
$4.18B
| $4.17M | ﹤0.01% |
52,158
+22,288
| +75% | +$1.97M |
2025 Q1
5 quarters
|
|
2266
Dyne Therapeutics
DYN
$3.37B
| $4.17M | ﹤0.01% |
187,915
+150,118
| +397% | +$2.79M |
2020 Q4
22 quarters
|
|
2267
PUT
Oneok
OKE
$58B
| $4.17M | ﹤0.01% |
+48,000
| New | +$4.23M |
2026 Q2
0 quarters
|
|
2268
Axogen
AXGN
$2.96B
| $4.17M | ﹤0.01% |
90,298
+77,779
| +621% | +$3.14M |
2016 Q2
40 quarters
|
|
2269
Highwoods Properties
HIW
$3.45B
| $4.17M | ﹤0.01% |
138,140
-6,612
| -5% | -$171K |
2013 Q2
52 quarters
|
|
2270
CALL
Corcept Therapeutics
CORT
$8.7B
| $4.16M | ﹤0.01% |
+47,900
| New | +$2.89M |
2026 Q2
0 quarters
|
|
|
2271
PUT
Corcept Therapeutics
CORT
$8.7B
| $4.16M | ﹤0.01% |
+47,900
| New | +$2.89M |
2026 Q2
0 quarters
|
|
2272
BOK Financial
BOKF
$7.95B
| $4.14M | ﹤0.01% |
29,831
-16,538
| -36% | -$2.19M |
2013 Q2
52 quarters
|
|
2273
DT Midstream
DTM
$12.5B
| $4.14M | ﹤0.01% |
28,200
+3,640
| +15% | +$515K |
2021 Q2
20 quarters
|
|
2274
IDEAYA Biosciences
IDYA
$3.05B
| $4.14M | ﹤0.01% |
110,970
+22,090
| +25% | +$676K |
2019 Q4
26 quarters
|
|
2275
Precigen
PGEN
$1.88B
| $4.13M | ﹤0.01% |
724,887
+343,522
| +90% | +$1.48M |
2013 Q3
51 quarters
|
|
Similar funds
Citigroup's Q2 2026 Portfolio in Review
As of Q2 2026, Citigroup held 6,442 positions worth $303B, up 29% from $235B the previous quarter. Its ten largest holdings account for 20% of the portfolio.
Citigroup deployed $27.6B of net new capital in Q2 2026, opening 555 new positions and adding to 3,283 existing holdings. Its largest new stake was Honeywell Aerospace: 579,875 shares worth $128M.
By sector, the portfolio is most concentrated in Miscellaneous at 39% of assets, down from 45% a quarter earlier, followed by Technology and Financials.
On the sell side, the largest reduction was iShares Russell 2000 ETF, an estimated $1.22B trimmed.
- Citigroup's largest Q2 2026 buy was Honeywell Aerospace: 579,875 shares worth $128M.
- Citigroup added most to NVIDIA in Q2 2026, an estimated $2.36B increase.
- Citigroup's biggest Q2 2026 reduction was iShares Russell 2000 ETF, cutting an estimated $1.22B.
- Citigroup fully exited Sealed Air in Q2 2026, selling an estimated $111M.
- Citigroup's ten largest holdings make up 20% of its $303B portfolio in Q2 2026.
- Citigroup opened 555 new positions and closed 760 in Q2 2026.
- Citigroup's portfolio value rose 29% quarter-over-quarter to $303B.
Based on Citigroup's 13F filing for Q2 2026, filed 3 Aug 2026.